A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Diet, High-FatPharmacokinetics
Interventions
DRUG

AL8326 tablets

"Sequence A group: on the 1st day, take a single dose of AL8326 tablets on an empty stomach. On the 15th day, take a single dose of AL8326 tablets after meals.~Sequence B group: on the 1st day after meal, take a single dose of AL8326 tablets; on the 15th day, take a single dose of AL8326 tablets on an empty stomach."

Trial Locations (1)

266000

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

Advenchen Laboratories Nanjing Ltd.

INDUSTRY